20Jan 2017

THE PREDICTIVE FACTORS OF THE CARDIOVASCULAR INFRINGEMENT IN THE RHEUMATOID ARTHRITIS

  • Service de cardiologie Hopital militaire Avicenne; CHU Mohammed VI Marrakech. Service de rhumatologie Hopital militaire Avicenne; CHU Mohammed VI Marrakech.
Crossref Cited-by Linking logo
  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

Cardiovascular disease incidence is increased in patients suffering rheuma-toid arthritis, The latter is a risk factor so important as the diabetes. In a prospective study, 40 patients with RA were compared with age- and sex-matched controls Results:- The intima-media thickness was significantly higher in patients with RA higher than control patients (0.759 mm vs 0.558 mm; P < 0.001). We found a higher TR, in patients with RA. But, C-HDL and C-LDL were are not significantly different betwen the both groups Conclusion:- Increased attention to cardiovascular risk in RA will be necessary to reduce the excess CV mortality and morbidity in RA patients. It appears that the excess risk that is observed in the RA population can be explained, in part, by promotion of CV disease through increased systemic inflammation associated with RA.


  1. Wallberg-Jonsson S,  Ohman  ML et al (1997),   J  Rheumatol  1997;24:445-5
  2. Navarro-Cano G,  Del  Rincon  I et al (2003),  . Association  of  mortality  with  disease  severity  in  rheumatoid  arthritis,  inde-pendent  of    Arthritis  Rheum  2003;48:2425–33
  3. Symmons DP, Gabriel SE( 2011) . Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol2011 ; 7 : 399-408
  4. Avina-Zubieta JA, Choi HK, Sadatsafavi M, et al (2008).Risk of cardiovascular mortality in patients with rheumatoid arthritis : a meta-analysis of observational studies. Arthritis Rheum 2008 ; 59 : 1690-7
  5. Watson DJ,  Rhodes  T,  Guess  H(2003).  All–cause  mortality  and  vascular  events among  patients  with  rheumatoid  arthritis  in  the  UK  general  practice research    J  Rheumol  2003;30:1196-202
  6. Solomon DH,  Curhan  GC et al (2004).  Car-diovascular  risks  in  women  with  and  without  rheumatoid    Arthritis Rheum  2004;50:3344–9
  7. Weyand CM,  Gornzy  JJ et al (2001).  T  cell  immunity  in  acute  coronary    Mayo  Clin  Proc 2001;76:1011–20
  8. Lindhardsen J, Ahlehoff O, Gislason GH, et al (2011).The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus : a Danish nationwide cohort study. Ann Rheum Dis 2011 ; 70 : 929-34.
  9. Kerola AM, Kauppi MJ et al (2012). How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear ? Ann Rheum Dis2012 ; 71 : 1606-15.
  10. Sandoo A, Veldhuijzen van Zanten JJ, et al (2011).Vascular function and morphology in rheumatoid arthritis : a systematic review. Rheumatology (Oxford). 2011 ;50 : 2125-39.
  11. Nurmohamed MT, van der Horst-Bruinsma I et al (2012). Cardiovascular and cerebrovascular diseases in ankylosing spondylitis : current insights. Curr Rheumatol Rep2012 ; 14 : 415-21.
  12. Jamnitski A, Symmons D, Peters MJ, et al (2013).Cardiovascular comorbidities in patients with psoriatic arthritis : a systematic review. Ann Rheum Dis 2013 ; 72 : 211-6.
  13. Park YB,  Ahn  CW et al (2002).  Athrosclerosis  in rheumatoid  arthritis:  morphologic  evidence  obtained  by  carotid  Arthritis  Rheum  2002;46:1714–9
  14. Kumeda Y,  Inaba  M,  Goto  H et al (2002).  Increased  thickness  of  yhe  arterial  intima-media  detected  by ultrasonographie  in  patients  with  rheumatoid    Arthritis  Rheum 2002;46(6):1489–97
  15. Mary J,  Moeller  E,  Davis  A,  et  al (2006).  Preclinical  carotid  atherosclerosis  in patients  with  rheumatoid    Ann  Intern  Med  2006;144:249–56
  16. Soubrier M, Bruckert E (2010). Should rheumatologists prescribe statins ? Rev Rhum 2010 ; 77 : 115 7.
  17. Boers M,  Nurmohamed  MT,  Doelman  CJ,  et  al (2003).  Influence  of  glucocorti-coids  and  disease  activity  ontotal  and  high  density  lipoprotein  cholesterol in  patients  with    Ann  Rheum  Dis  2003;62:842–5
  18. Georgiadis AN,  Papavasilou  EC et al (2006).  Atherogenic  lipid  pro-file  is  a  feature  characteristic  of  patients  with  early  rheumatoid  arthritis: effect  of  early  treatment–a  prospective,  controlled    Arthritis  Res  Ther 2006;8:1–7
  19. wallberg-Jonsson S,  Backman  C et al (2001).  Increased  prevalence of  atherosclerosis  in  patients  with  medium  term  rheumatoid    J Rheumatol  2001;28:2597–602
  20. Flipo RM(2007).  Glucocorticoids  and  cardiovascular  events  in  rheumatoid arthritis.  A  population-based  cohort    Arthritis  Rheum  2007;56: 820–30
  21. Del Rincon  I,  O’Leary  DH,  Haas  RW (2004).  Effect  of  glucocorticoids on  the  arteries  in  rheumatoid    Arthritis  Rheum  2004;50: 3813–22.
  22. Choi HK,  Hernan  MA et al (2002).  Methotrexate  and mortality  in  patients  with  rheumatoid  arthritis:  a  prospective    Lancet 2002;359:1173–7
  23. McInnes IB,  McCarrey  DW,  Sattar  N (2004).  Do  statins  offer  therapeu-tic  potential  in  inflammatory  arthritis?  Ann  Rheum  Dis  2004;63: 1535–7

[H. Jallal, S. Arioua, A.Zbitou, L. Bendriss, A. Khatouri, M. Ghazi and R. Naiman. (2017); THE PREDICTIVE FACTORS OF THE CARDIOVASCULAR INFRINGEMENT IN THE RHEUMATOID ARTHRITIS Int. J. of Adv. Res. 5 (1). 187-193] (ISSN 2320-5407). www.journalijar.com


jallal hamid
3eme hopital militaire laayoune maroc

DOI:


Article DOI: 10.21474/IJAR01/2736       DOI URL: http://dx.doi.org/10.21474/IJAR01/2736


Share this article